EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benzothiazole–Triazole–Indazole Conjugates: Design, Characterization, and Preliminary In Vitro MTT-Based Antiproliferative Evaluation

Fatima E Laghchioua, Maurizio Viale, Renata Silva iD, Fernando Remião iD, José A S Cavaleiro iD, M Amparo F Faustino iD, El Mostapha Rakib iD, Maria Graça P M S Neves iD, Nuno M M Moura iD

Molecules · 2026

DOI: 10.3390/molecules31193452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Fatima E Laghchioua und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Chemistry, Materials and Catalysis, Faculty of Sciences and Technics, Sultan Moulay Slimane University, Beni-Mellal BP 523, M…. Hauptthemen laut MEDLINE: Triazoles, Benzothiazoles, Antineoplastic Agents, Indazoles. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, University of Aveiro, Erasmus+ program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new library of benzothiazole–triazole–indazole conjugates (5a–s) was efficiently synthesized via a Cu(I)-catalyzed azide–alkyne cycloaddition (CuAAC) strategy. The approach involved the preparation of alkynylated indazoles and benzothiazole–azide derivatives, followed by click-chemistry cycloaddition to provide triazole-linked heterocyclic hybrids in good-to-excellent yields (72–95%), demonstrating the robustness of the modular synthetic design. In silico evaluation using SwissADME indicated that several compounds display physicochemical profiles potentially compatible with early-stage hit exploration, although the relatively high TPSA values suggest that membrane permeability may be limited for some derivatives. The antiproliferative activity of conjugates 5a–s was assessed against A2780 (ovarian), A549 (lung), and MDA-MB-231 (breast) cancer cell lines using the MTT assay. Several conjugates exhibited greater in vitro antiproliferative activity toward A2780 cells, with 5r emerging as the most active derivative of the series (IC50 = 15.7 ± 1.6 μM). In addition, 5b showed notable antiproliferative activity against the MDA-MB-231 cell line (IC50 = 10.8 ± 2.9 μM), highlighting cell-line-dependent antiproliferative profiles. Preliminary structure–activity relationship analysis suggested that electronic effects alone do not fully account for the observed antiproliferative activity, and that substituent position, steric factors, and cell-line-dependent factors may also play important roles in modulating biological response. Given the micromolar activity, the MTT-based nature of the assay, and the absence of non-tumoral cell line data, these compounds are best regarded as chemical starting points for further optimization and mechanistic investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesBenzothiazolesAntineoplastic AgentsIndazolesHumansCell ProliferationCell Line, TumorStructure-Activity RelationshipDrug Screening Assays, AntitumorDrug DesignMolecular StructureClick ChemistryMDA-MB-231 Cells

Stichwörter der Autor:innen

1,2,3-triazoleCuAACSwissADMEantiproliferative activitybenzothiazoleindazole

Substanzen

TriazolesBenzothiazolesAntineoplastic AgentsIndazolesbenzothiazole

Autor:innen und Institutionen

  • Laboratory of Molecular Chemistry, Materials and Catalysis, Faculty of Sciences and Technics, Sultan Moulay Slimane University, Beni-Mellal BP 523, Morocco.
  • U.O. Bioterapie, IRCCS Azienda Ospedaliera Metropolitana (IRCCS AOM), L.go R. Benzi, 10, 16132 Genova, Italy.
  • UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
  • LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.
  • Higher School of Technology, Sultan Moulay Slimane University, Fquih Ben Salah BP 336, Morocco.

ORCID-Profile: Renata Silva, Fernando Remião, José A S Cavaleiro, M Amparo F Faustino, El Mostapha Rakib, Maria Graça P M S Neves, Nuno M M Moura

Förderung

  • Fundação para a Ciência e Tecnologia
  • University of Aveiro
  • Erasmus+ program
  • Italian Ministry of Health, Italy

Zitieren

APA

Laghchioua, F. E., Viale, M., Silva, R., Remião, F., Cavaleiro, J. A. S., Faustino, M. A. F., Rakib, E. M., Neves, M. G. P. M. S., & Moura, N. M. M. (2026). Benzothiazole–Triazole–Indazole Conjugates: Design, Characterization, and Preliminary In Vitro MTT-Based Antiproliferative Evaluation. Molecules. https://doi.org/10.3390/molecules31193452

Vancouver

Laghchioua FE, Viale M, Silva R, Remião F, Cavaleiro JAS, Faustino MAF, et al. Benzothiazole–Triazole–Indazole Conjugates: Design, Characterization, and Preliminary In Vitro MTT-Based Antiproliferative Evaluation. Molecules. 2026. doi:10.3390/molecules31193452

BibTeX
@article{Laghchioua2026,
  author = {Laghchioua, Fatima E and Viale, Maurizio and Silva, Renata and Remião, Fernando and Cavaleiro, José A S and Faustino, M Amparo F and Rakib, El Mostapha and Neves, Maria Graça P M S and Moura, Nuno M M},
  title = {Benzothiazole–Triazole–Indazole Conjugates: Design, Characterization, and Preliminary In Vitro MTT-Based Antiproliferative Evaluation},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31193452}
}
Kostenlos starten →